Copyright
©The Author(s) 2019.
World J Gastroenterol. Nov 14, 2019; 25(42): 6311-6321
Published online Nov 14, 2019. doi: 10.3748/wjg.v25.i42.6311
Published online Nov 14, 2019. doi: 10.3748/wjg.v25.i42.6311
Figure 1 Downregulation of miR-30c and its prognostic significance in pancreatic cancer.
A: MiR-30c expression in the Gene Expression Omnibus (GEO) dataset GSE24279. B: MiR-30c expression in the GEO dataset GSE60978. C: Quantitative real-time polymerase chain reaction detection of the expression of miR-30c in tissues collected at the First Affiliated Hospital of Zhengzhou University. D: Kaplan–Meier analysis of survival of pancreatic cancer patients (n = 40). The data are presented as the mean ± standard deviation. P < 0.05 was considered statistically significant. eP < 0.001 vs nontumor group. ZZU: Zhengzhou University.
- Citation: Sun LL, Cheng M, Xu XD. MicroRNA-30c inhibits pancreatic cancer cell proliferation by targeting twinfilin 1 and indicates a poor prognosis. World J Gastroenterol 2019; 25(42): 6311-6321
- URL: https://www.wjgnet.com/1007-9327/full/v25/i42/6311.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i42.6311